We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




Automated Hematology Platform Offers High Throughput Analytical Performance

By LabMedica International staff writers
Posted on 05 Jan 2024

HORIBA Medical (Kyoto, Japan) has introduced

labmedica.com/expo/product/17057/automated-hematology-platform-model-helo-2-0" target="_blank">HELO 2.0, a high throughput automated hematology platform with CE-IVDR approval, marking an evolution from its predecessor. This upgraded high-end hematology solution has been designed in response to customer feedback, aiming to fulfill the comprehensive needs of high throughput, fully automated hematology. Tailored for mid to large-scale laboratories, HELO 2.0 is a modular and highly flexible system, offering scalability and numerous configurations.

Available in three standard configurations, HELO 2.0 is suitable for both single-lab and multi-site operations, functioning as a standalone or integrated with a tracking system. The system’s track-based architecture allows continuous loading from multiple points, supplemented by a new automatic quality control transfer, enhancing sample workflow management for heightened efficiency. The system smartly distributes samples and quality control tubes to the designated analyzer and conducts blood smears based on reflex rules. Configurable with up to six analyzers and six slide preparation systems on a single track, it offers over 200 preloaded rules in the hematology expert validation station.

HELO 2.0 introduces innovative 8 Part Differential (DIFF) leukocyte results, providing a comprehensive analysis from a single blood sample. HORIBA's Yumizen H1500 and H2500 analyzers deliver complete blood count (CBC) and DIFF results, along with a total immaturity measurement for leukocyte count, ideally suited for oncology pathologies. Additional enhancements include a Nucleated Red Blood Cell count free from platelet aggregate interference and three new large platelet parameters devoid of fluorescence. Eleven additional parameters have been incorporated across its three quality controls. Designed to be environmentally friendly, HELO 2.0 has received the 2023 Medical Device Network Excellence Award in the Environmental category, highlighting its eco-friendly approach. Notably, the Yumizen H2500 analyzer requires only six reagents compared to the typical 8-15, significantly reducing reagent usage, waste, toxicity, and packaging.

“One of the biggest challenges for laboratories is to obtain accurate results for an ever-increasing number of samples within shorter turnaround times,” said Arnaud Pradel, General Manager, HORIBA Medical. “So, listening to our customers’ feedback, we have again applied our hematology expertise and heritage for innovation to further enhance our HELO automated hematology platform. In the HELO 2.0 we offer an even more flexible and efficient system to reduce slide review rate that provides an optimum solution to the ever-evolving needs of many different laboratories.”


Gold Member
Troponin T QC
Troponin T Quality Control
New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
New
Mumps Test
ReQuest MUMPS IgM Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The innovative doublet configuration and annular illumination overcome traditional metalens limitations (Photo courtesy of Tao Li and Jiacheng Sun/Nanjing University)

High-Resolution Metalens Doublet Microscope to Enhance Diagnostic Capabilities

Metalenses mark a groundbreaking leap in optical technology. Unlike traditional microscope objectives that rely on curved glass surfaces, metalenses utilize nanoscale structures to manipulate light at... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.